M Booth Health named Peter Matheson Gay as the agency’s first Chief Impact Officer on the heels of the health communication consultancy’s strongest performing year marked by double-digit growth and signature account wins. 

Marina Maher Communications (MMC) announced that Diana Farina has joined the agency as Group Senior Vice President, Client Excellence. According to MMC management, Farina will strive to revolutionize the client experience through rapid innovation of team design and agile ways of working, which the agency recognizes that clients and prospects of all sizes are craving. This appointment comes on the heels of the agency’s expanded leadership roster and several new agency assignments in healthcare, consumer wellness and scientific communications.

Ogilvy Health announced the hiring of industry strategist Liz Kane to lead the agency’s Insights, Brand and Medical Strategy offerings. Ogilvy also shared the promotion of Corina Kellam, who will lead a newly formed Experience & Innovation Team. The two proven leaders will join Ogilvy Health’s powerhouse executive leadership board, led by Ogilvy Health CEO Kim Johnson.

LEO Pharma A/S, a global leader in medical dermatology, announced the appointment of Brian Hilberdink as Executive Vice President and President of LEO Pharma Inc. in the United States, effective March 14, 2022.

Jen Dobrzelecki was appointed president of Goodfuse, an award-winning boutique agency built to fuse humanity into communications. The 25-year agency veteran has a proven track record for building award-winning cultures and campaigns across the consumer, healthcare, technology, and corporate sectors.

epocrates, an athenahealth Inc. company that delivers digital clinical decision support to prescribers, shared its commitment to accelerate the company’s fast-growing commercial business and further invest in and innovate its commercial product offerings, following a period of tremendous change in the pharmaceutical industry. To help enhance and broaden epocrates’ services, the company recently brought on Matt Titus – an industry veteran of 13 years – to serve as the organization’s vice president, chief commercial officer.

Ogilvy Health’s new chief creative officer Adam Hessel talks about why he crossed over into healthcare from the consumer sector, what he brings to Ogilvy Health, and where he wants to see the healthcare industry go in general when it comes to creativity.

Marina Maher Communications (MMC) announced the hire of Joshua Wu, PhD., as Senior Vice President, Performance Analytics.

Led by new CEO Dr. Yvonne Greenstreet, Alnylam Pharmaceuticals has a stated ambition to transition the RNA interference therapeutics trailblazer to a top 5 biotech – measured by market capitalization – within the next five years.

Hal Barron, who guided the reinvigoration of the pharmaceutical direction at GlaxoSmithKline, is departing the company as GSK undergoes a planned demerger later during 2022.